Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review
- PMID: 15530168
- PMCID: PMC535537
- DOI: 10.1186/1743-7075-1-12
Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review
Abstract
There are likely many scenarios and pathways that can lead to metabolic syndrome. This paper reviews mechanisms by which the accumulation of visceral adipose tissue (VAT) may contribute to the metabolic syndrome, and explores the paradigm of a critical VAT threshold (CVATT). Exceeding the CVATT may result in a number of metabolic disturbances such as insulin resistance to glucose uptake by cells. Metabolic profiles of patients with visceral obesity may substantially improve after only modest weight loss. This could reflect a significant reduction in the amount of VAT relative to peripheral or subcutaneous fat depots, thereby maintaining VAT below the CVATT. The CVATT may be unique for each individual. This may help explain the phenomena of apparently lean individuals with metabolic syndrome, the so-called metabolically normal weight (MONW), as well as the obese with normal metabolic profiles, i.e., metabolically normal obese (MNO), and those who are "fit and fat." The concept of CVATT may have implications for prevention and treatment of metabolic syndrome, which may include controlling dietary carbohydrates. The identification of the CVATT is admittedly difficult and its anatomical boundaries are not well-defined. Thus, the CVATT will continue to be a work in progress.
Figures



Similar articles
-
Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women?Metabolism. 2003 May;52(5):599-604. doi: 10.1053/meta.2003.50095. Metabolism. 2003. PMID: 12759890 Clinical Trial.
-
What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?J Clin Endocrinol Metab. 2001 Mar;86(3):1020-5. doi: 10.1210/jcem.86.3.7365. J Clin Endocrinol Metab. 2001. PMID: 11238480
-
Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy.Growth Horm IGF Res. 2006 Jul;16 Suppl A:S62-7. doi: 10.1016/j.ghir.2006.03.004. Epub 2006 Apr 18. Growth Horm IGF Res. 2006. PMID: 16624603 Review.
-
Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response.J Clin Endocrinol Metab. 2011 Jan;96(1):E73-82. doi: 10.1210/jc.2010-1575. Epub 2010 Nov 3. J Clin Endocrinol Metab. 2011. PMID: 21047918
-
Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.Horm Metab Res. 2002 Nov-Dec;34(11-12):616-21. doi: 10.1055/s-2002-38256. Horm Metab Res. 2002. PMID: 12660870 Review.
Cited by
-
A specific dose of grape seed-derived proanthocyanidins to inhibit body weight gain limits food intake and increases energy expenditure in rats.Eur J Nutr. 2017 Jun;56(4):1629-1636. doi: 10.1007/s00394-016-1209-x. Epub 2016 Apr 2. Eur J Nutr. 2017. PMID: 27039093
-
A Moderate Low-Carbohydrate Low-Calorie Diet Improves Lipid Profile, Insulin Sensitivity and Adiponectin Expression in Rats.Nutrients. 2015 Jun 11;7(6):4724-38. doi: 10.3390/nu7064724. Nutrients. 2015. PMID: 26110252 Free PMC article.
-
Depot-specific mRNA expression programs in human adipocytes suggest physiological specialization via distinct developmental programs.PLoS One. 2024 Oct 14;19(10):e0311751. doi: 10.1371/journal.pone.0311751. eCollection 2024. PLoS One. 2024. PMID: 39401200 Free PMC article.
-
Effects of chronic ethanol consumption on levels of adipokines in visceral adipose tissues and sera of rats.Acta Pharmacol Sin. 2010 Apr;31(4):461-9. doi: 10.1038/aps.2010.12. Epub 2010 Mar 8. Acta Pharmacol Sin. 2010. PMID: 20208553 Free PMC article.
-
Antenatal exposure to betamethasone induces placental 11β-hydroxysteroid dehydrogenase type 2 expression and the adult metabolic disorders in mice.PLoS One. 2018 Sep 13;13(9):e0203802. doi: 10.1371/journal.pone.0203802. eCollection 2018. PLoS One. 2018. PMID: 30212527 Free PMC article.
References
-
- Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991;14:1132–1143. - PubMed
-
- Lamarche B. Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease. Coron Artery Dis. 1998;9:473–481. - PubMed
-
- Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes. 2000;49:883–888. - PubMed
LinkOut - more resources
Full Text Sources
Medical